Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry
Sponsor: Centennial Medical Center, Nashville, Tennessee
Terminated
The study has been closed by the Sponsor.
Other Atrial Fibrillation trials with similar outcome
Listed as NCT06052358, this observational or N/A phase trial focuses on Atrial Fibrillation and GI Bleeding and remains terminated or withdrawn. Sponsored by Centennial Medical Center, Nashville, Tennessee, it has been updated 5 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
5 versions recorded-
Oct 2025 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Nov 2024 — Oct 2025 [monthly]
Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
First recorded
Aug 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centennial Medical Center, Nashville, Tennessee
- Kansas City Heart Rhythm Institute, Overland Park, Kansas
- Kansas City Heart Rhythm Research Foundation
- Los Robles Health System, Los Robles, California
- Texas Cardiac Arrythmia Institute, Austin, Texas
For direct contact, visit the study record on ClinicalTrials.gov .